Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today announced it has signed agreements to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of joint surface and preservation solutions for active patients.
Read the full article: Anika Therapeutics to Acquire Parcus Medical and Arthrosurface //
Source: https://www.businesswire.com/news/home/20200106005356/en/Anika-Therapeutics-Acquire-Parcus-Medical-Arthrosurface